Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Simon Athlin, Christer Lidman, Anders Lundqvist, Pontus Naucler, Anna C. Nilsson, Carl Spindler, Kristoffer Strålin & Jonas Hedlund. (2018) Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infectious Diseases 50:4, pages 247-272.
Read now
Read now
Carl Spindler, Kristoffer Strålin, Lars Eriksson, Gunilla Hjerdt-Goscinski, Hans Holmberg, Christer Lidman, Anna Nilsson, Åke Örtqvist & Jonas Hedlund. (2012) Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012. Scandinavian Journal of Infectious Diseases 44:12, pages 885-902.
Read now
Read now
Anna Hugosson, Martin Hjorth, Sverker Bernander, Berndt E. B. Claesson, Agneta Johansson, Helena Larsson, Peter Nolskog, Judit Pap, Nils Svensson & Peter Ulleryd. (2007) A community outbreak of Legionnaires’ disease from an industrial cooling tower: Assessment of clinical features and diagnostic procedures. Scandinavian Journal of Infectious Diseases 39:3, pages 217-224.
Read now
Read now
Jonas Hedlund, Kristoffer Strålin, Åke Örtqvist, Hans Holmberg & THE COMMUNITY-ACQUIRED PNEUMONIA WORKING GROUP OF THE SWEDISH SOCIETY OF INFECTIOUS DISEASES. (2005) Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scandinavian Journal of Infectious Diseases 37:11-12, pages 791-805.
Read now
Read now
Articles from other publishers (16)
H. Lawrence, W. S. Lim & T. M. McKeever. (2020) Variation in clinical outcomes and process of care measures in community acquired pneumonia: a systematic review. Pneumonia 12:1.
Crossref
Crossref
S. Rhedin, I. Galanis, F. Granath, A. Ternhag, J. Hedlund, C. Spindler & P. Naucler. (2017) Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study. Clinical Microbiology and Infection 23:4, pages 247-252.
Crossref
Crossref
Keiichi Mikasa, Nobuki Aoki, Yosuke Aoki, Shuichi Abe, Satoshi Iwata, Kazunobu Ouchi, Kei Kasahara, Junichi Kadota, Naoki Kishida, Osamu Kobayashi, Hiroshi Sakata, Masahumi Seki, Hiroki Tsukada, Yutaka Tokue, Fukumi Nakamura-Uchiyama, Futoshi Higa, Koichi Maeda, Katsunori Yanagihara & Koichiro Yoshida. (2016) JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy – The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG. Journal of Infection and Chemotherapy 22:7, pages S1-S65.
Crossref
Crossref
. (2014) JAID/JSC 感染症治療ガイドライン ―呼吸器感染症―. Kansenshogaku Zasshi 88:1, pages 1-109.
Crossref
Crossref
Francesco Blasi, Javier Garau, Jesús Medina, Marco Ávila, Kyle McBride & Helmut Ostermann. (2013) Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respiratory Research 14:1, pages 44.
Crossref
Crossref
J. D. Chalmers, M. Al-Khairalla, P. M. Short, T. C. Fardon & J. H. Winter. (2010) Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. Journal of Antimicrobial Chemotherapy 65:4, pages 608-618.
Crossref
Crossref
Niclas Johansson, Mats Kalin, Christian G. Giske & Jonas Hedlund. (2008) Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease 60:3, pages 255-261.
Crossref
Crossref
Gerald R. Donowitz. (2006) Community-acquired pneumonia: How far have we come?. Current Infectious Disease Reports 8:6, pages 419-420.
Crossref
Crossref
Madeleine Kais, Carl Spindler, Mats Kalin, Åke Örtqvist & Christian G. Giske. (2006) Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR. Diagnostic Microbiology and Infectious Disease 55:3, pages 169-178.
Crossref
Crossref
Martin Kolditz, Michael Halank & Gert H??ffken. (2006) Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired Pneumonia. Treatments in Respiratory Medicine 5:6, pages 371-383.
Crossref
Crossref
J.J. Oosterheert, M.J.M. Bonten, M.M.E. Schneider & I.M. Hoepelman. (2005) Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands. Clinical Microbiology and Infection 11:12, pages 992-998.
Crossref
Crossref
Alberto Capelastegui, Pedro P. España, Jose M. Quintana, Inmaculada Gorordo, María S. Gallardo, Itsaso Idoiaga & Amaia Bilbao. (2005) Management of community-acquired pneumonia and secular trends at different hospitals. Respiratory Medicine 99:3, pages 268-278.
Crossref
Crossref
Joseph F. PlouffeJr.Jr. & Daniel R. Martin. (2004) Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infectious Disease Clinics of North America 18:4, pages 963-974.
Crossref
Crossref
M Lalot, F Veyckemans, E Ketelslegers & F Roelants. (2004) Une cause inhabituelle de détresse respiratoire en salle de soins post-interventionnelle. Annales Françaises d'Anesthésie et de Réanimation 23:2, pages 138-141.
Crossref
Crossref
Taina Juvén, Jussi Mertsola, Matti Waris, Maija Leinonen & Olli Ruuskanen. (2004) Clinical response to antibiotic therapy for community-acquired pneumonia. European Journal of Pediatrics 163:3, pages 140-144.
Crossref
Crossref
Thomas M FileJrJr. (2003) Community-acquired pneumonia. The Lancet 362:9400, pages 1991-2001.
Crossref
Crossref